85.00
price down icon17.83%   -18.44
 
loading

Warum fällt Novo Nordisk Adr-Aktie (NVO)?

Wir haben während der Handelssitzung 2024-12-20 einen Rückgang der Aktie Novo Nordisk Adr (NVO) um 17.83% festgestellt. Obwohl dies auf normale Volatilität oder verschiedene interne und externe Faktoren zurückzuführen sein kann, beachten Sie bitte, dass wir die Situation aktiv beobachten und so schnell wie möglich zeitnahe Updates bereitstellen!
2023-11-03:

Novo Nordisk A/S Stock (NVO) dropped by 2.73% from $100.93 to $98.17 in the trading on Friday November 3, 2023. The reason why NVO stock down today is due to the insider selling. Novo Nordisk divulged in a regulatory document that Camilla Sylvest, its head of commercial strategy and corporate affairs, sold 15,000 shares of the company. The sale price was 694.37 kroner ($98.76), making for a total of just over 10.4 million kroner (about $1.5 million).

2023-09-20:

Novo Nordisk (NVO) was down 49.4% on Wednesday trading. The company is splitting its shares, which marks a milestone in Novo Nordisk's share price appreciation, as well as making the size of options contracts more manageable to smaller investors.

https://seekingalpha.com/article/4636288-novo-nordisk-what-the-stock-split-means-for-traders-and-investors

drug_manufacturers_general JNJ
$144.47
price up icon 0.62%
$175.58
price up icon 2.37%
drug_manufacturers_general MRK
$98.05
price down icon 1.48%
drug_manufacturers_general NVS
$97.11
price up icon 0.35%
drug_manufacturers_general PFE
$26.36
price up icon 2.29%
Kapitalisierung:     |  Volumen (24h):